Financials

  • Market Capitalization 276.8 M
  • Employee 86
  • Founded 2014
  • CEO N/A
  • Website www.sab.bio
  • Headquarter Delaware, United States
  • FIGI BBG00YHY0G24
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.05
Relación precio/flujo de caja
7.07

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
6960
XOMAP
XOMA Royalty Corporation - 8.625% Series A Cumulative Perpetual Preferred Stock
24.97 USD0.00%+0.16%-2.12%-4.00%503.77 M USD
7007
RCKTW
Rocket Pharmaceuticals, Inc. - Warrant
0.0029 USD0.00%0.00%-42.00%-92.54%394.19 M USD
7179
SRZNW
Surrozen, Inc. - Warrant
0.0066 USD-48.44%-31.25%-60.71%-63.13%253.80 M USD
7273
HUMAW
Humacyte, Inc. - Warrant
0.0091 USD0.00%-9.00%-54.50%-98.18%157.63 M USD